Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Chicago
Big Ten Cancer Research Consortium
Memorial Sloan Kettering Cancer Center
Fondazione Italiana Linfomi - ETS
M.D. Anderson Cancer Center
University of Washington
UNC Lineberger Comprehensive Cancer Center
Emory University
University of Washington
Thomas Jefferson University
M.D. Anderson Cancer Center
Assiut University
Roswell Park Cancer Institute
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Chinese PLA General Hospital
St. Petersburg State Pavlov Medical University
Columbia University
New York Medical College
Memorial Sloan Kettering Cancer Center
The Lymphoma Academic Research Organisation
Ohio State University Comprehensive Cancer Center
Columbia University
Weill Medical College of Cornell University
M.D. Anderson Cancer Center
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Mayo Clinic
Fred Hutchinson Cancer Center
Columbia University
St. Petersburg State Pavlov Medical University
Mayo Clinic
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Cologne
Mayo Clinic
Chinese PLA General Hospital
M.D. Anderson Cancer Center
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Columbia University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Washington
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Memorial Sloan Kettering Cancer Center
Ciusss de L'Est de l'Île de Montréal
University of Michigan Rogel Cancer Center
OHSU Knight Cancer Institute